PMA device
Alinity i AFP
Abbott Laboratories · Kit, Test, Alpha-Fetoprotein For Neural Tube Defects (LOK, Class III) · First FDA decision Jun 25, 2019, newest May 23, 2020Genetic and newborn screening
Last checked: Nov 20, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
2
PMA pathway
Device trials
0
Naming "Alinity i AFP"
MAUDE reports
18
Brand "Alinity i AFP", since 2015
PubMed studies
0
Mentioning "Alinity i AFP"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing Alinity i AFP
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology, with pictures of the device
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 2 of 2 decisions filed under this name.
- Alinity i AFPPMA supplement
P120008-S014 · Decided May 23, 2020 · 68 days after receipt · Normal 180 Day Track No User Fee
Device type: KIT, TEST, ALPHA-FETOPROTEIN FOR NEURAL TUBE DEFECTS (LOK) · Laboratory Medicine & Pathology
1 more FDA decisions with a free account
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
No Medicare coverage document has a title matching this device or device type. Many devices are paid under existing codes without one.
Clinical trials
Device studies on ClinicalTrials.gov that name "Alinity i AFP", any status and sponsor, newest update first.
No registered device study names "Alinity i AFP".
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "Alinity i AFP", and for the whole product code for context.
This brand
18 reports: 18 malfunction, 0 injury, 0 death
Whole product code LOK
140 reports: 140 malfunction, 0 injury, 0 death
Newest reports for this brand
- Alinity i AFP Reagent KitMalfunction
Abbott Ireland Diagnostics Division
3008344661-2026-00116 · Received Aug 3, 2026 · Event dated Jul 21, 2026
Device type: Kit, Test, Alpha-Fetoprotein For Neural Tube Defects (LOK)
Device problem as coded: Low Test Results
Patient problem as coded: No Clinical Signs, Symptoms or Conditions
4 more reports with a free account
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recall in FDA's data is linked to these FDA numbers.
Published research
The most relevant PubMed records for "Alinity i AFP"[tiab]. The summary above synthesizes these.
No PubMed record mentions this device by name.
Other devices of this type
Also filed under product code LOK.
- Access AFP (on DxI 9000 Analyzer)Beckman Coulter, Inc. · PMA 2025
- Architect AfpAbbott Laboratories · PMA 2020
- Atellica IM Alpha Fetoprotein (AFP)Siemens Healthcare Diagnostics, Inc. · PMA 2024
- Axsym AfpAbbott Laboratories · PMA 2011
- Advia Centaur Afp AssaySiemens Healthcare Diagnostics, Inc. · PMA 2018
- Immulite/Immulite 1000/IMMULITE 2000/IMMULITE 2500 AfpSiemens Healthcare Diagnostics, Inc. · PMA 2010
- Immulite 2000 AfpSiemens Healthcare Diagnostics, Inc. · PMA 2026
- ARCHITECT AFP, Alinity i AFPAbbott Laboratories · PMA 2023
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.